CSat Investment Advisory’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-243
Closed -$53K 914
2020
Q3
$53K Buy
243
+21
+9% +$4.45K ﹤0.01% 661
2020
Q2
$42K Buy
+222
New +$38.9K 0.01% 695
2019
Q4
Sell
-2,107
Closed -$143K 1085
2019
Q3
$143K Buy
2,107
+387
+23% +$25.5K 0.05% 258
2019
Q2
$114K Buy
+1,720
New +$100K 0.04% 278

Other funds holding TDOC

CSat Investment Advisory's TDOC Position: Q4 2020 in Review

CSat Investment Advisory sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 243 shares — an estimated $53K sold.

CSat Investment Advisory first reported a position in TDOC in Q2 2019 and held it in 4 quarters. The position peaked at $143K in Q3 2019. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • CSat Investment Advisory reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 243 Teladoc Health shares in Q4 2020, an estimated $53K.
  • CSat Investment Advisory first reported a position in Teladoc Health in Q2 2019 and held it in 4 quarters.
  • CSat Investment Advisory's Teladoc Health position peaked at $143K in Q3 2019.
  • 901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.